Related Topics:
Facility ID: 02132RMSTN423LA
Facility Name and Address: ARMSTRONG PHARMACEUTICALS INC . 423 LAGRANGE ST WEST ROXBURY, MA 02132 Parent Company: AMPHASTAR PHARMACEUTICALS INC Industry: Pharmaceutical Preparation Manufacturing (325412) Chemical: Dichlorotetrafluoroethane (CFC-114) Reports: View TRI Facility profile report for this facility View TRI Form R submissions by this facility |
|
*You can navigate within the map with your mouse. |
Production Related Waste Management for Selected Chemical
lchemid=0000076142
Chart Options1: |
Waste Management Comparison -
Display facility comparison report for this industry and chemical
Pollution Prevention Activities for Selected Chemical
Reporting Year | Section 8.10: Newly Implemented Source Reduction Activity | Section 8.10: Methods to Identify Activity | Section 8.11: Optional Pollution Prevention Information* |
---|---|---|---|
2011 |
Source Reduction:: W42: Substituted raw materials
|
Methods to Identify SR Opportunities: T11: Other
|
W42: Armstrong currently is developing new products by using hfa as propellant. Armstrong management team is dedicated to reduce toxic emission and use environment friendly material. Source Reduction - Cfcs were phased out and armstrong is developing new formulation product. Source Reduction - Armstrong stopped its cfcs prodcution on august 13th, 2011 and phased out its cfcs product by the end of 2011. Armstrong closed its 423 lagrange street facility permanently, all equipment were decommissioned and all hazardous wastes were cleaned out by clean harbors inc. Some extra cfc producsts were cleaned out and sent to hudson technologies to recyle and proper disposal. Armstrong is currently developig new product by using hfa as propellant. Armstrong does not use and produce any cfcs product any more. The building was sold to a real estate developer. |
2010 | Other Environmental Practices - Epinephrine mist will be phased out by the end of 2011. Armstrong will stop production by the end of august and shut down prodcution line permanently. The facility will be closed permanently by the end of this year. Armstrong cleaned whole facility, more expired old samples were sent to recycle. | ||
2009 | Source Reduction - Armstrong updated all pipes in unit #3 and reduced tailing in 2008 year. Due to depression, armstrong pharmaceuticals shut down production line unit #3 for 3 months in the year 2009(April, may and june), production was reduced. Production unit #3 (Epinephrine line) is the only production line armstrong uses right now. We did clean up and shut down one facility and found more epinephrine waste units. Units #3 (Epinephrine line) will be phased out by december 31,2011. We will not use any cfc chemicals by that time. The unit #3 will be closed permanently. Details please see:Http://Www.Fda.Gov/Ohrms/Dockets/98fr/E8-27436.Htm | ||
2008 |
Source Reduction:: W32: Improved procedures for loading, unloading, and transfer operations
Source Reduction:: W52: Modified equipment, layout, or piping Source Reduction:: W58: Other process modifications |
Methods to Identify SR Opportunities: T04: Participative team management
Methods to Identify SR Opportunities: T04: Participative team management Methods to Identify SR Opportunities: T04: Participative team management |
Other Environmental Practices - Installation of the fluorochemical emission elimination delivery system to reduce the emissions associated with the cfc deliveries. Replacement of the piping and valves associated with the cfc lines. Repaired the cfc receiver. |
2007 |
Source Reduction:: W32: Improved procedures for loading, unloading, and transfer operations
|
Methods to Identify SR Opportunities: T04: Participative team management
|
|
2002 |
Source Reduction:: W19: Other changes in operating practices
Source Reduction:: W72: Modified spray systems or equipment |
Methods to Identify SR Opportunities: T03: Materials balance audits
Methods to Identify SR Opportunities: T04: Participative team management |
|
2001 |
Source Reduction:: W19: Other changes in operating practices
Source Reduction:: W72: Modified spray systems or equipment |
Methods to Identify SR Opportunities: T03: Materials balance audits
Methods to Identify SR Opportunities: T04: Participative team management |
|
2000 |
Source Reduction:: W13: Improved maintenance scheduling, recordkeeping, or procedures
|
Methods to Identify SR Opportunities: T01: Internal pollution prevention opportunity audit(s)
|
|
1999 |
Source Reduction:: W58: Other process modifications
|
Methods to Identify SR Opportunities: T01: Internal pollution prevention opportunity audit(s)
|
|
1998 |
Source Reduction:: W13: Improved maintenance scheduling, recordkeeping, or procedures
|
Methods to Identify SR Opportunities: T01: Internal pollution prevention opportunity audit(s)
|